BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 17456574)

  • 41. Liquid chromatography-tandem mass spectrometry analysis of 17-hydroxyprogesterone in dried blood spots revealed matrix effect on immunoassay.
    Han L; Tavakoli NP; Morrissey M; Spink DC; Cao ZT
    Anal Bioanal Chem; 2019 Jan; 411(2):395-402. PubMed ID: 30456606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapy monitoring in congenital adrenal hyperplasia by dried blood samples.
    Wieacker I; Peter M; Borucki K; Empting S; Roehl FW; Mohnike K
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):867-71. PubMed ID: 25781526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ketosteroid profiling using Girard T derivatives and electrospray ionization tandem mass spectrometry: direct plasma analysis of androstenedione, 17-hydroxyprogesterone and cortisol.
    Johnson DW
    Rapid Commun Mass Spectrom; 2005; 19(2):193-200. PubMed ID: 15593251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of 17 α-hydroxyprogesterone in bloodspots by liquid chromatography tandem mass spectrometry.
    Salter SJ; Cook P; Davies JH; Armston AE
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):126-34. PubMed ID: 24842631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantification of Dehydroepiandrosterone, 11-Deoxycortisol, 17-Hydroxyprogesterone, and Testosterone by Liquid Chromatography-Tandem Mass Spectrometry (LC/MS/MS).
    Munar A; Frazee C; Garg U
    Methods Mol Biol; 2016; 1378():273-9. PubMed ID: 26602139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
    Nordenström A; Wedell A; Hagenfeldt L; Marcus C; Larsson A
    Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X; Zhou J; Ye J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
    Votava F; Török D; Kovács J; Möslinger D; Baumgartner-Parzer SM; Sólyom J; Pribilincová Z; Battelino T; Lebl J; Frisch H; Waldhauser F;
    Eur J Endocrinol; 2005 Jun; 152(6):869-74. PubMed ID: 15941926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitation of 17-OH-progesterone (OHPG) for diagnosis of congenital adrenal hyperplasia (CAH).
    Singh RJ
    Methods Mol Biol; 2010; 603():271-7. PubMed ID: 20077078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
    Allen DB; Hoffman GL; Fitzpatrick P; Laessig R; Maby S; Slyper A
    J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis of adrenal cortical dysfunction by liquid chromatography-tandem mass spectrometry.
    Kao PC; Machacek DA; Magera MJ; Lacey JM; Rinaldo P
    Ann Clin Lab Sci; 2001 Apr; 31(2):199-204. PubMed ID: 11337910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of 21-deoxycortisol, a marker of congenital adrenal hyperplasia, in blood by atmospheric pressure chemical ionization and electrospray ionization using multiple reaction monitoring.
    Cristoni S; Cuccato D; Sciannamblo M; Bernardi LR; Biunno I; Gerthoux P; Russo G; Weber G; Mora S
    Rapid Commun Mass Spectrom; 2004; 18(1):77-82. PubMed ID: 14689562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.
    Dörr HG; Sippell WG
    J Clin Endocrinol Metab; 1993 Jan; 76(1):117-20. PubMed ID: 8421074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Twenty Years of Neonatal Screening for Congenital Adrenal Hyperplasia in North-Eastern Italy: Role of Liquid Chromatography-Tandem Mass Spectrometry as a Second-Tier Test.
    Cavarzere P; Camilot M; Palma L; Lauriola S; Gaudino R; Vincenzi M; Antoniazzi F; Teofoli F; Piacentini G
    Horm Res Paediatr; 2022; 95(3):255-263. PubMed ID: 35350013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.
    de Hora MR; Heather NL; Webster D; Albert BB; Hofman PL
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3390-e3399. PubMed ID: 34058748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of monoclonal antibodies against 17α-hydroxyprogesterone for newborn screening of congenital adrenal hyperplasia.
    Morejón García G; García de la Rosa I; González Reyes EC; Rubio Torres A; Quintana Guerra JM; Hernández Marín M; Pérez Mora PL; Feal Carballo S; Lafita Delfino Y; Pupo Infante M; Castells Martínez EM; Rosabal Poloshkov A; Hernández Pérez L
    Clin Chim Acta; 2018 Oct; 485():311-315. PubMed ID: 30006291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
    Castro PS; Rassi TO; Araujo RF; Pezzuti IL; Rodrigues AS; Bachega TASS; Silva IN
    J Pediatr Endocrinol Metab; 2019 May; 32(5):499-504. PubMed ID: 31028712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
    Lee JE; Moon Y; Lee MH; Jun YH; Oh KI; Choi JW
    Ann Clin Lab Sci; 2008; 38(3):235-40. PubMed ID: 18715851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous determination of 17alpha-hydroxypregnenolone and 17alpha-hydroxyprogesterone in dried blood spots from low birth weight infants using LC-MS/MS.
    Higashi T; Nishio T; Uchida S; Shimada K; Fukushi M; Maeda M
    J Pharm Biomed Anal; 2008 Sep; 48(1):177-82. PubMed ID: 18571354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants.
    Sarafoglou K; Gaviglio A; Hietala A; Frogner G; Banks K; McCann M; Thomas W
    J Pediatr; 2014 May; 164(5):1136-40. PubMed ID: 24582106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.